Breaking News

ASIT biotech Receives GMP Certification

Site in Liège, Belgium to manufacture in-house the active pharmaceutical ingredient of its leading product for grass pollen allergies

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

ASIT biotech, a clinical stage biopharmaceutical company focused breakthrough allergy immunotherapy products, received Good Manufacturing Practices (GMP) certification for its manufacturing site in Liège, Belgium, from the Federal Agency for Medicines and Health Products (FAMHP).   The certification follows a 2-day site inspection and constructive dialogue with the Agency. It allows ASIT biotech to manufacture in-house the active pharmaceutical ingredient of its leading product for grass polle...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters